Optiscan Imaging Ltd signs a know-how agreement with Mayo Clinic to co-develop and clinically test a digital endomicroscopic imaging system for robotic surgery, with an initial focus on breast cancer.
This collaboration aims to combine Optiscan's engineering expertise with Mayo Clinic's robotic surgery knowledge to enhance patient outcomes and accelerate the growth of the robotic-assisted surgery market.
ASX Code: OIL